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Abstract
Background: The World Health Organization (WHO), like many other organisations around the world, has recognised the need to use more
rigorous processes to ensure that health care recommendations are informed by the best available research evidence. This is the 12th of a series
of 16 reviews that have been prepared as background for advice from the WHO Advisory Committee on Health Research to WHO on how to
achieve this.
Objectives: We reviewed the literature on incorporating considerations of equity in guidelines and recommendations.
Methods: We searched PubMed and three databases of methodological studies for existing systematic reviews and relevant methodological
research. We did not conduct systematic reviews ourselves. Our conclusions are based on the available evidence, consideration of what WHO
and other organisations are doing and logical arguments.
Key questions and answers: We found few directly relevant empirical methodological studies. These answers are based largely on logical
arguments.
When and how should inequities be addressed in systematic reviews that are used as background documents for
recommendations?
• The following question should routinely be considered: Are there plausible reasons for anticipating differential relative effects across
disadvantaged and advantaged populations?
• If there are plausible reasons for anticipating differential effects, additional evidence should be included in a review to inform judgments about the
likelihood of differential effects.
What questions about equity should routinely be addressed by those making recommendations on behalf of WHO?
• The following additional questions should routinely be considered:
• How likely is it that the results of available research are applicable to disadvantaged populations and settings?
• How likely are differences in baseline risk that would result in differential absolute effects across disadvantaged and advantaged populations?
• How likely is it that there are important differences in trade-offs between the expected benefits and harms across disadvantaged and advantaged
populations?
• Are there different implications for disadvantaged and advantaged populations, or implications for addressing inequities?
What context specific information is needed to inform adaptation and decision making in a specific setting with regard to
impacts on equity?
• Those making recommendations on behalf of WHO should routinely consider and offer advice about the importance of the following types of
context specific data that might be needed to inform adaptation and decision making in a specific setting:
• Effect modifiers for disadvantaged populations and for the likelihood of differential effects
• Baseline risk in relationship to social and economic status
• Utilization and access to care in relationship to social and economic status
• Costs in relationship to social and economic status
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• Ethics and laws that may impact on strategies for addressing inequities
• Availability of resources to address inequities
What implementation strategies are likely be needed to ensure that recommendations are implemented equitably?
• Organisational changes are likely to be important to address inequities. While it may only be possible to consider these in relationship to specific
settings, consideration should be given to how best to provide support for identifying and addressing needs for organisational changes. In countries
with pervasive inequities institutional, cultural and political changes may first be needed.
• Appropriate indicators of social and economic status should be used to monitor the effects of implementing recommendations on disadvantaged 
populations and on changes in social and economic status.
Background
The World Health Organization (WHO), like many other
organisations around the world, has recognised the need
to use more rigorous processes to ensure that health care
recommendations are informed by the best available
research evidence. This is the 12th of a series of 16 reviews
that have been prepared as background for advice from
the WHO Advisory Committee on Health Research to
WHO on how to achieve this.
Braveman and Gruskin define equity as "the absence of
disparities in health that are systematically associated with
social advantage or disadvantage" [1]. The message is
made clearer by Margaret Whitehead's definition of ineq-
uity: "differences in health which are not only unneces-
sary and avoidable but, in addition, are considered unfair
and unjust" [2]. Inequities in health and health care are
well documented in relationship to social and economic
factors, including Place of residence (e.g. rural, urban,
inner city, Race/ethnicity/culture, Occupation, Gender,
Religion, Educational level, Socioeconomic status and
Social capital (availability of neighbourhood support,
social stigma, civic society) (PROGRESS) [3].
Disadvantaged populations almost always have poorer
health [4], poorer access to health care [5], and receive
poorer quality health care [6]. To the extent that recom-
mendations influence what is done, they can improve the
overall health of the population but have no impact on
inequities, reduce inequities or exacerbate them regardless
of the overall effects on population health. There has been
a growing interest in taking equity into consideration in
clinical practice guidelines [7,8]. However, consideration
of inequities has generally been lacking [7]. For example,
AGREE and other instruments for assessing the quality of
guidelines do not include items on equity or the fairness
of the recommendations [9].
In this paper we address the following questions:
￿ When and how should inequities be addressed in sys-
tematic reviews that are used as background documents
for recommendations?
￿ What questions about equity should routinely be
addressed by those making recommendations on behalf
of WHO?
￿ What context specific information is needed to inform
adaptation and decision making in a specific setting with
regard to impacts on equity?
Related questions about adaptation, applicability and
transferability are addressed in another paper in this series
[10].
What WHO is doing now
"WHO has embraced the elimination of health inequities
as an important target and supports the dual goals of
equity and efficiency for health services. WHO's data gath-
ering on inequalities in health status and access to services
is shaped by and in turn informs its advocacy and norma-
tive activities that aim to reduce health inequities. Besides
collecting relevant data broken down by group, WHO
attempts both to relate these data to health determinants
(e.g., membership in less privileged social groups and
exposure to various hazards) and to develop and dissem-
inate interventions to improve conditions for members of
such groups" [11].
Nonetheless, we are not aware of any specific documents
that provide guidance as to how equity should be taken
into account in WHO guidelines or recommendations or
of any studies or descriptions of current practice. The
WHO guidelines for guidelines do not currently provide
any explicit advice regarding how to take account of
equity.
What other organisations are doing
Clinical practice guidelines typically focus on the effec-
tiveness of interventions (Will adherence to a recommen-
dation do more good than harm?), occasionally on cost-
effectiveness (Are the net benefits worth the costs?), and
rarely on equity (Are the recommendations fair?) [7].
More recently, several guideline developers have begun to
consider equity explicitly and systematically, including,
for example, the Australian NHMRC [7], INCLEN [8], the
GRADE Working Group, and the National Institute forHealth Research Policy and Systems 2006, 4:24 http://www.health-policy-systems.com/content/4/1/24
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Health and Clinical Excellence (NICE) in the UK, which
now has an extended mandate including public health
guidance and reducing health inequalities, after the
Health Development Agency (HDA) became part of NICE
in 2005 [12]. The HDA was established in 2000 to
develop the evidence base to improve health and reduce
health inequalities. It worked in partnership with profes-
sionals and practitioners across a range of sectors to trans-
late that evidence into practice. Other countries that have
had a major political commitment to reducing inequities
in health include the Netherlands [13], Thailand, and
Chile [14].
Methods
The methods used to prepare this review are described in
the introduction to this series [15]. Briefly, the key ques-
tions addressed in this paper were vetted amongst the
authors and the ACHR Subcommittee on the Use of
Research Evidence (SURE). We did not conduct a full sys-
tematic review. We searched PubMed and three databases
of methodological studies (the Cochrane Methodology
Register [16], the US National Guideline Clearinghouse
[17], and the Guidelines International Network [18]) for
existing systematic reviews and relevant methodological
research that address these questions. We did not conduct
systematic reviews ourselves. The answers to the questions
are our conclusions based on the available evidence, con-
sideration of what WHO and other organisations are
doing, and logical arguments.
This paper is based in large part on a workshop on
addressing inequities held in Oslo August 31 to Septem-
ber 1, 2005 [19], background documentation for that
workshop [20-23], and a reference list generated during
and subsequent to the workshop. We searched PubMed
using (clinical practice guidelines or public health guide-
lines) and (equity or equality) and related articles for ref-
erences [7] and [23]. We searched the Cochrane
Methodology Register using equity or equality.
Findings
Our database searches yielded few references and we
found few directly relevant empirical methodological
studies, consistent with the findings of other reviews
[22,23]. For example, the literature search and corre-
spondence with guideline developers worldwide by the
NHMRC located no examples of where clinical practice
guideline developers explicitly incorporated evidence on
socioeconomic position and health into generic guide-
lines, except for when guidelines were developed for spe-
cific disadvantaged sub-populations [22]. This is
consistent with the findings of the Health Development
Agency in England. They observed that there is a very large
literature that describes the problem of inequalities and a
very much smaller one describing interventions that could
reduce inequalities [24].
When and how should inequities be addressed in 
systematic reviews that are used as background documents 
for recommendations?
Evidence of the effects of interventions on inequities is
sparse and difficult to search for [25]. For example, Tsikata
and colleagues found that only 10% of controlled trials
assessed the efficacy of the intervention across socioeco-
nomic subgroups [26]. Similarly, Ogilvie and colleagues
found that in Cochrane reviews of controlled studies of
tobacco control both the reviews and the primary studies
in those reviews rarely assessed the impact of the interven-
tion across socioeconomic factors [27]. Systematic reviews
tend not to provide evidence on differential effectiveness
[27-33]. Searches of electronic databases in many fields,
particularly for social interventions and more upstream
interventions, may miss much relevant evidence [31-33].
Publication bias may be a problem [25]. Because there is
limited direct evidence of differential effects of interven-
tions across socioeconomic groups, it will generally be
necessary to search for and include a wider scope of evi-
dence to support or refute plausible hypotheses of differ-
ential effects, or the effects of interventions on reducing
inequities.
Although there are clear arguments for exploring modera-
tor effects in systematic reviews, subgroup analyses can be
misleading both because of inadequate power (resulting
in false negative conclusions) and multiple testing (result-
ing in false positive conclusions) [34-38]. The results
observed in subgroups may differ by chance from the
overall effect identified by the meta-analysis, and the sub-
group findings may not be confirmed by subsequent large
trials [36,39]. Paradoxically, the best estimate of the out-
come of the intervention in a sub-group may come from
discounting the results of the sub-group analysis and
using the overall results (Stein's paradox) [36,40]. General
guidelines for interpreting subgroup analyses can be
applied to subgroup analyses based on socioeconomic
factors [40,41].
What questions about equity should routinely be 
addressed by those making recommendations on behalf of 
WHO?
Additional questions that should be considered in rela-
tionship to equity include questions about the applicabil-
ity of the evidence to disadvantaged populations,
differences in values, and the implications of these differ-
ences. General guidelines for considering the applicability
of evidence can be applied to considering the applicability
of evidence to disadvantaged populations [42], including
differences in absolute effects due to differences in base-
line risk. The trade-offs between the benefits and harms ofHealth Research Policy and Systems 2006, 4:24 http://www.health-policy-systems.com/content/4/1/24
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an intervention may be different because of differences in
the relative or absolute effects of an intervention or
because of differences in values [8]. For example, if an out-
come, such as the ability to quickly return to or stay at
work, is more important to disadvantaged populations,
this might tip the balance between the benefits, harms
and costs of an intervention (for example antiretrovirals
for AIDS) in favour of intervening. Differences in any of
these factors can result in different implications and rec-
ommendations for disadvantaged populations or specific
recommendations for addressing inequities [8].
What context specific information is needed to inform 
adaptation and decision making in a specific setting with 
regard to impacts on equity?
While evidence about the effects of interventions gener-
ally comes from global research, it is necessary to take into
account factors in a specific setting to inform decisions
about what to do. These factors include each of the follow-
ing in relationship to socioeconomic factors: the presence
of effect modifiers that have been identified in the global
research, baseline risk, utilization and access to care, and
costs. In addition, it is necessary to take into account rele-
vant ethical and legal standards in a specific setting, and
the availability of resources to address inequities.
Although this information is beyond the scope of a review
or international guidelines or recommendations, interna-
tional groups can systematically consider the need for
these different types of information in specific settings
and provide guidance regarding the importance of obtain-
ing such information and practical strategies for doing so
and integrating context specific information into deci-
sion-making processes.
What implementation strategies are likely be needed to 
ensure that recommendations are implemented equitably?
Because disadvantaged populations generally have poorer
access to care and often receive poorer quality care, organ-
isational changes are likely to be needed to address ineq-
uities in health care. Organisational changes are also
likely to be necessary to implement interventions targeted
at social determinants of health. Identifying necessary
organisational changes, and barriers and facilitators of
implementing change requires context specific knowledge
and decisions. Nonetheless, general guidance and support
for what information to consider, possible strategies to
address common barriers and facilitators, and general
frameworks for planning organisational changes and
implementation strategies can be provided internation-
ally. In countries with pervasive inequities institutional,
cultural and political changes may first be needed.
Similarly, although local data are needed to monitor the
effects of implementing recommendations, guidance can
be provided regarding appropriate indicators of social gra-
dients and measures of change (e.g. in the ratio of quintile
1 to 5, or concentration indices) to use in order to moni-
tor the effects of implementing recommendations on dis-
advantaged populations and on changes in social
gradients. Because the evidence for interventions to
reduce inequities will commonly be weak, it is generally
important to ensure that monitoring and evaluations are
as rigorous as possible to ensure that intended effects are
achieved and unintended adverse effects are avoided.
What 'maps' are available of the different dimensions of 
inequity locally?
Equity and inequity are not one-dimensional phenom-
ena. They consist of a number of dimensions that include
economic status, occupation, gender, ethnicity, class,
caste, religion, status grouping, age, disability, place of res-
idence, geographical location, and manifest sexual orien-
tation. These different dimensions are of varying salience
in any given social context. For example caste and religion
are more frequently significant in pre industrial systems
while occupation tends to be dominant in industrial sys-
tems. It is also important to note that the importance of
these various dimensions relative to each other also varies,
as the dimensions overlap and overlay each other. The
health effects of inequities are a product of the interplay
of these different dimensions. It is therefore important to
describe systematically the dimensions, and if possible
their relative salience, in any given social arrangement.
Discussion
Inequities are rarely addressed in clinical practice guide-
lines. Evidence of the effects of public health and health
policy interventions on reducing inequities is generally
weak or lacking [43]. As a consequence, advice regarding
how to address inequities in recommendations must to a
large extent rely on the application of general methodo-
logical studies and principles, for example in relationship
to subgroup analyses and applicability. While addressing
inequities is a fundamental concern at the heart of WHO's
mission, at present there appears to be inadequate guid-
ance on how best to do this in developing and imple-
menting recommendations.
Although we have not found empirical descriptions of
WHO's current practices, it is reasonable to assume that
inequities are not being addressed systematically and
transparently. This assumption rests in part on documen-
tation that WHO guidelines generally have not adhered to
standards such as AGREE [44,45]. WHO may be more
likely to address inequities than many other organisa-
tions, given its mission. However, the available evidence
suggests that inequities are generally not well addressed in
most systematic reviews and clinical practice guidelines. It
is only recently that attention has been given to the meth-Health Research Policy and Systems 2006, 4:24 http://www.health-policy-systems.com/content/4/1/24
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ods used to address inequities, both for clinical and public
health interventions [7,21,46].
Further work
Although we have not conducted a systematic review of
the relevant literature, a more systematic review is not
likely to have results or implications that are substantially
different, given the sparseness of methodological research
in this area. This assumption is supported by the NHMRC
review [7] and a NHS HTA review of addressing equity in
economic analyses [23]. However, growing attention is
being paid to this area and there are areas of research that
can further inform specific issues, such as the selection of
indicators of socioeconomic status in relationship to spe-
cific interventions or conditions. Thus, while we do not
believe that WHO should undertake further work at this
time, it would be valuable for WHO or others to under-
take and keep up-to-date systematic methodology reviews
that address specific aspects of how to address inequities
in systematic reviews, guidelines and recommendations.
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